Massive Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.60 M
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.79 Cr
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -5.88%
- Profit Growth 3.65%
- Ebitda -14.74%
- Net Worth 7.23%
- Total Assets -3.07%
About Massive Pharmaceuticals
Massive Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 July 2006 and has a history of 18 years and six months. Its registered office is in Tiruchirappalli, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹1.79 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Govindarajan Mohan and Pappaian Prasath serve as directors at the Company.
Company Details
-
Location
Tiruchirappalli, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TN2006PTC060577
-
Company No.
060577
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Massive Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindarajan Mohan
|
Director | 18-Jul-2006 | Current |
|
Pappaian Prasath
|
Director | 18-Jul-2006 | Current |
Financial Performance of Massive Pharmaceuticals.
Massive Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.88% decrease. The company also saw a slight improvement in profitability, with a 3.65% increase in profit. The company's net worth moved up by a moderate rise of 7.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Massive Pharmaceuticals?
In 2023, Massive Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.94 M
₹10.00 M
Charges Breakdown by Lending Institutions
- Others : 1.30 Cr
- Hdfc Bank Limited : 0.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2024 | Hdfc Bank Limited | ₹1.05 M | Open |
| 18 Mar 2024 | Hdfc Bank Limited | ₹1.58 M | Open |
| 30 Jan 2021 | Hdfc Bank Limited | ₹1.13 M | Open |
| 30 Jan 2021 | Hdfc Bank Limited | ₹1.18 M | Open |
| 02 Aug 2016 | Others | ₹1.30 Cr | Open |
How Many Employees Work at Massive Pharmaceuticals?
Massive Pharmaceuticals has a workforce of 18 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Massive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Massive Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.